Sfoglia per RIVISTA
FRONTIERS IN ENDOCRINOLOGY
Collezione ASL Torino 4

  

Items : 2

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2022 Apr 27;13:899616. doi: 10.3389/fendo.2022.899616. eCollection 2022

2022
ASL Torino 4
AOU San Luigi di Orbassano

Terzolo M; Mariash CN; Gordon MB; Kerr JM; Kargi AY; Feelders RA; Bancos I; Pivonello R; Ellison N; Moraitis AG;

Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2022 Jan 4;12:793262. doi: 10.3389/fendo.2021.793262. eCollection 2021.

2021
ASL Torino 4
AOU San Luigi di Orbassano

Moraitis AG; Bali U; Puglisi S; Simeoli C; Ferrigno R; Terzolo M; Munster PN; Pivonello R;